You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Methodologies and Tools for Securing Medical Device Systems in Integrated Clinical Environments (ICE)

    SBC: REAL-TIME INNOVATIONS, INC.            Topic: DHP15004

    Security considerations for dynamically composable Integrated Clinical Environments (ICE) are critical not only because laws such as the Health Insurance Portability and Accountability Act mandate it, but also because security attacks can have serious safety consequences for patients. Real-Time Innovations (RTI) proposes to model security requirements for a set of key care environments and compreh ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  2. Novel Intraocular Visualization Tools

    SBC: Neuroctix Corp            Topic: DHP15016

    A surgical insert for an 18-gauge needle has been developed incorporating two working channels, one for forward-looking 3D imaging, and a second working channel for a therapeutic embodiment (cutting, coagulation, precision injection of drugs, etc). We propose here an approach to scale down the insert to allow it to be incorporated in smaller gauge (20, 22) needles with significant size, weight and ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  3. Optimization of Cryoprotectants, Cryotherapeutics, and Protocols for Cryopreservation of Large Tissue Systems

    SBC: X-Therma Inc.            Topic: DHP15013

    X-Therma Inc. aims to deliver highly effective, non-toxic cryoprotective agents (CPAs) using unique peptidomimetic polymers which not only mimic the outstanding ice inhibiting effects of naturally occurring antifreeze proteins, but also conquer the cons such as high cost and protease degradation. Widely used biopreservation media contain DMSO above cytotoxic concentrations, an unavoidable concern ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  4. Methodologies and Tools for Securing Medical Device Systems in Integrated Clinical Environments (ICE)

    SBC: HOW MANY ENGINEERS INC            Topic: DHP15004

    Develop an interoperable specification language for the security properties of an ICE supervisor, network controller, logger, and supervisor app components for an interoperable MAP/ICE system architecture that is PNP interoperable, both human and machine readable, defined by a clearly delineated scope and purpose, suitable for both human and automated analysis at assembly time and run time, extens ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  5. Intraoperative Scanning Laser Ophthalmoscope

    SBC: HEDGEFOG RESEARCH INC.            Topic: DHP15016

    Ocular injuries have constituted approximately 13% of all casualties from Operation Enduring Freedom/Iraqi Freedom. Of 76 patients that sustained open globe injuries and underwent surgery at Walter Reed National Military Medical Center to restore vision, 38% ultimately went blind. In many cases, severely scarred corneas preclude adequately visualizing the retina and other intraocular structures t ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  6. Rapid Detection of Borrelia burgdorferi (Lyme disease) from Ticks

    SBC: VECTOR TEST SYSTEMS            Topic: DHP15006

    VecTOR Test Systems, Inc will develop assay for rapid detection of the Lyme disease pathogen Borrelia burgdorferi in ticks in a field setting. In Phase I, feasibility of the concept will be determined by developing a prototype assay that has the potential to detect Borrelia burdorferi. The overall objective is to develop product/s that will quickly and accurately determine whether arthropods colle ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  7. Rapid Detection of Borrelia burgdorferi (Lyme disease) from Ticks

    SBC: NANOCOMPOSIX, INC.            Topic: DHP15006

    Lyme disease is the most common tick-borne disease in North America and one of the fast-growing infectious diseases in the United States. An inexpensive, portable and accurate diagnostic device for the detection of Borrelia bacteria in the deer tick will be developed. The diagnostic device will consist of an efficient extractor for disrupting the hard exoskeleton on the tick, an ultra-sensitive ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  8. Stabilized Antimicrobial Peptides to Combat Multidrug-Resistant Biofilm

    SBC: ALLVIVO VASCULAR, INC.            Topic: DHP15007

    Infections involving multidrug resistant organisms (MDROs) post a substantial threat to military populations. Critical barriers to progress in the treatment of wound infections are the need for therapeutics effective against MDROs and therapeutics effective against biofilms. The goal of this application is to further develop two novel engineered antimicrobial peptides (eCAPs) for treatment of MDRO ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  9. Spectroscopic System for Therapeutic Drug Monitoring (THERASPEC)

    SBC: CHROMOLOGIC LLC            Topic: A13082

    ChromoLogic LLC (CL) is developing a Spectroscopic System for Therapeutic Drug Monitoring (THERASPEC), to meet the Armys need for a compact, robust system to assess the peak and trough therapeutic drug concentrations in blood to provide real-time TDM in fixed and field medical facilities. The THERASPEC prototype is based on spectroscopic

    SBIR Phase II 2015 Department of DefenseDefense Health Agency
  10. Universal Microfluidic Device Platform to Enable Real-Time Continuous Measurement of Biomarkers of Coagulopathy Directly in Trauma Victims

    SBC: APTITUDE MEDICAL SYSTEMS INC            Topic: DHP15012

    Traumatic hemorrhage is the primary mechanism of death in potentially survivable combat injuries, and is the leading cause of death for civilians under the age of 44. Trauma-induced coagulopathy develops quickly, resulting in a hypocoagulable state with increased bleeding, and a 4-fold increase in mortality. The protocolized but blind provision of large volumes of blood products, while beneficial ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government